SCHEMBL2766538

SCHEMBL2766538

COc1cc(F)c(N2CCC3(CC2)OCCO3)cc1F

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.51
ALDH1A1 P00352 7/20 0.39
POLB P06746 3/20 0.39
LGMN Q99538 1/20 0.39
KMT2A Q03164 2/20 0.39
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
ACACB O00763 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17893742 0.90 FFAR4 (0.41) FFAR4ALDH1A1POLBLGMNKMT2A
SCHEMBL17543468 0.85 FFAR4 (0.43) FFAR4ALDH1A1LGMNKMT2ATSHR
SCHEMBL17543251 0.84 FFAR4 (0.43) FFAR4ALDH1A1POLBKMT2ATSHR
SCHEMBL17542687 0.80 FFAR4 (0.38) FFAR4ALDH1A1LGMNKMT2ATSHR
SCHEMBL27178764 0.79 FFAR4 (0.37) FFAR4ALDH1A1POLBLGMNKMT2A
SCHEMBL30738835 0.79 FFAR4 (0.37) FFAR4ALDH1A1POLBLGMNKMT2A
SCHEMBL17893718 0.79 DRD2 (0.47) ALDH1A1POLBLGMNKMT2ATSHR
SCHEMBL17543650 0.79 POLB (0.48) ALDH1A1POLBLGMNKMT2ATSHR
SCHEMBL15720835 0.79 POLB (0.48) ALDH1A1POLBLGMNKMT2ATSHR
SCHEMBL17543661 0.78 FFAR4 (0.46) FFAR4ALDH1A1TSHRMAPTSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA FFAR4 2828/4885ALDH1A1 2953/4885POLB 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.